InflaRx N.V.

Prof. Riedemann received his M.D. training at Freiburg – and Stanford University (Germany / USA). He spent several years in basic science at the University of Michigan in the field of complement immunology and inflammation before completing his board certification as General Surgeon at the Hannover Medical School where he still holds a Professorship for Experimental Surgery. He specialized as Intensive Care Physician and has been appointed Vice Director of Intensive Care Medicine at the Friedrich Schiller University in Jena. His research has been awarded with several national and international awards (e.g. Hugo-Schottmüller-Award, Hans-Liniger-Award etc.) and he has received extensive extra mural funding and published over 50 high ranked scientific publications. He actively serves as member on 2 Boards of Directors of large scientific governmental programs. As founder of InflaRx, Prof. Riedemann combines in-depth basic science experience and advanced clinical knowledge in the field of inflammation and acute care. Prof. Riedemann is heading InflaRx as CEO since 2007.


Bank Name InflaRx N.V.
Stock Exchange NASDAQ
Symbol IFRX
Sector Healthcare
Country United States
World Region Amarica
CEO Dr. Niels C. Riedemann M.D., Ph.D.
Employees 21
Registered Year 2007